Agilon Health

AGL

Market cap $1.45B

Does Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here is how Agilon Health (AGL) and Humacyte, Inc. (HUMA) have performed compared to their sector so far this year.

Agilon (AGL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Here is how Agilon Health (AGL) and Amarin (AMRN) have performed compared to their sector so far this year.

Agilon (AGL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Shares of Agilon Health cratered in 2025, driven by financial underperformance and a guidance suspension.

Agilon Health Inc. (NYSE:AGL) shares are soaring on Thursday as the company recently announced an increase in its full-year 2026 guidance. The company operates and manages a network of independent physicians.

agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript

Agilon Health (AGL) came out with quarterly earnings of $1.8 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to break-even earnings per share a year ago.

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.